Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03947983 · ClinicalTrials.gov registry record · NA
Sensor-controlled Digital Game for Heart Failure Self-management
A NA study of Heart Failure, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 2
- Study locations
NCT03947983: Completed NA study of Heart Failure, sponsored by University of Texas at Austin.
NCT03947983 is a NA study of Heart Failure that has completed, run by University of Texas at Austin. The registered enrollment target is 38 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03947983, a NA study of Heart Failure, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study evaluates a sensor-controlled digital game (SCDG) to motivate self-management behaviors of weight monitoring and physical activity in older adults with heart failure (HF). Half of the participants will receive the SCDG app and weight monitoring and physical activity sensors and the other half will receive only the weight monitoring and physical activity sensors.
Primary Outcome
This outcome will be measured by collecting number of days with weight-monitoring data. This measure will be collected from sensor logs within the apps for both intervention group (IG) and control group (CG).
Conditions Studied
Interventions
- BEHAVIORAL Sensor-controlled digital game (SCDG)
- BEHAVIORAL Sensor Only
Study Locations (2)
Texas
- Cardiac Floor, Seton Medical Center Austin - Austin
- Cardiac Rehabilitation Center, Seton Medical Center Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2019-11-12 |
| Est. Completion | 2021-01-30 |
| Phase | NA |
What the finished NCT03947983 record still lists
NCT03947983 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Sensor-controlled digital game (SCDG) is the first listed.
NCT03947983 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03947983 about?
NCT03947983 is a clinical study titled "Sensor-controlled Digital Game for Heart Failure Self-management". This study evaluates a sensor-controlled digital game (SCDG) to motivate self-management behaviors of weight monitoring and physical activity in older adults with heart failure (HF). Half of the participants will receive the SCDG app and weight monitoring and physical activity sensors and the other ...
What is the current status of trial NCT03947983?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2019-11-12. Estimated completion is 2021-01-30.
What conditions does trial NCT03947983 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT03947983?
The interventions under investigation include: Sensor-controlled digital game (SCDG) (BEHAVIORAL), Sensor Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT03947983?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03947983 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03947983's enrollment target sits among peer trials
38 310th of 397 higher than 88 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI